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A B S T R A C T
Aims: Oxidative stress induced by diabetes mellitus (DM) is considered as one of the main causes of infertility in
diabetic patients. The aim of the present study was to assess the eﬀect of Tempol – as a synthetic antioxidant- on
the testis oxidative stress and sperm parameters in type 2 diabetic (T2D) rats.
Main methods: Twenty male Wistar rats were divided into 4 groups. Control groups (C) and diabetic groups (D);
the control and diabetic groups received Tempol (100mg/kg) for one month. Sperm parameters and oxidative
stress biomarkers were evaluated in testicular tissue.
Key ﬁndings: The results demonstrated that administration of Tempol in diabetic rats improved sperm motility
and viability and decreased the count of abnormal sperms. Also Tempol decreased the fasting blood sugar (FBS)
and lipid peroxidation (LPO). In addition, Tempol signiﬁcantly increased total antioxidant capacity (TAC) levels
in testis tissue of T2D rats. Histopathological changes were also improved in the diabetic treated group.
Signiﬁcance: Taken together, the results indicated that Tempol improved fertility parameters in a diabetic rat
through reducing oxidative stress.
1. Introduction
Diabetes mellitus (DM) is a common multifactorial metabolic dis-
order characterized by chronic hyperglycemia and defect in the meta-
bolism of macromolecules [1]. DM is a global health challenge; based
on reports from the International Diabetes Federation (IDF), about 415
million people suﬀered from DM worldwide in 2017, expected to rise to
645 million people by 2040 [2,3]. Etiologically, DM might result from
defect in synthesize, secretion, and function of insulin. DM is usually
classiﬁed as: type 1 diabetes (T1D), type 2 diabetes (T2D), gestational
diabetes (GD) and other types [4]. The most common form of DM is the
type 2 diabetes, usually aﬀecting adults, which mainly results from
systemic resistance to insulin [7]. The main feature of DM is a chronic
elevated blood sugar (hyperglycemia) which in long term damages
various body organs, resulting in multiple physiological complications
such as nephropathy, retinopathy, and neuropathy [5].
Insulin regulates the metabolism of glucose in sperm cells through
various glucose transporters (GLUTs) [7]. Not surprisingly, therefore,
the reproductive system is signiﬁcantly aﬀected in male diabetic pa-
tients as a result of defect in glucose metabolism and elevated reactive
oxygen species (ROS) [8,9].
Oxidative stress is also a common feature of DM pathogenesis that
reﬂects an imbalance between production and degradation of free ra-
dicals [6]. The sperm cells membrane has a high content of unsaturated
fatty acids, turning them vulnerable to oxidative damage by free radi-
cals [10]. DM mediated oxidative stress thus aﬀects both the quality
and quantity of semen which causes infertility problems [9] [11,12].
About 45% of infertility is related to male factors, including gene
mutations, infectious diseases, ejaculatory duct obstruction, testicular
varicose, and radiation. However, reasons for almost half of the in-
fertility cases in men are unknown (idiopathic) [13]. Recent studies
show that oxidative stress is one of the factors that might mediate the
male infertility [14]. Excessive amounts of ROS alongside a reduced
antioxidant capacity in the spermatozoa and seminal plasma cause
defects in the membrane and damage to the DNA of sperm cells
[15–17].
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Antioxidant supplements might be helpful in empowering the an-
tioxidant defense system against oxidative damages caused by free ra-
dicals. Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), a
synthetic antioxidant that mimics the role of superoxide dismutase
(SOD), for example, has been shown that reduces the oxidative stress
mediated cell damage in several rodent models [18]. Nevertheless, its
antioxidant role in many diseases associated with oxidative stress has
not yet been studied. Therefore, to further evaluate the eﬃciency of
Tempol in reducing the DM related oxidative damage, we investigated
the eﬀect of Tempol on sperm and oxidant/antioxidant parameters in
testicular tissue of T2D rats.
2. Material and methods
2.1. Animals and work design
In this study, twenty male Wistar rats weighing 220 ± 10 were
used. The rats were maintained in an animal house at the Hamadan
University of Medical Sciences in standard conditions (in cages, in a
ventilated room at 22 ± 2 °C and on a 12-h light/12-h dark cycle). The
animals were randomly divided into 4 groups (n=5), including; C:
control group receiving normal saline, D: T2D group, C+T: control
group receiving Tempol 100mg/kg and D+T: T2D group receiving
Tempol 100mg/kg. The study was approved by the Medical Ethics
Review Board of Hamadan University of Medical Sciences (IR.UMSHA.
REC.1394.163).
For induction of T2D, streptozotocin (STZ) (65mg/kg) and nicoti-
namide (110mg/kg) were injected intraperitoneally to rats [19–21].
After 72 h, fasting blood glucose was measured using glucometer (Ac-
cuchek; Roche, Germany). Animals with fasting blood glucose equal to
and>150mg/dl were considered as T2D rats [22]. Treatment was
carried out by IP injection for 30 days. After the treatment period,
fasted rats were anesthetized with ketamine, their testis tissue were
removed and stored for further evaluation.
2.2. Epididymal sperm preparation
The left testis cauda epididymis of each rat was removed and
minced in 2ml of Ham's F10 medium (pre-warmed in 37 °C and 5%
CO2). The cauda epididymis was cut into small pieces to release more
sperm. The sperm suspension was then incubated in 37 °C for 15min
[23]. The sperm parameters including sperm count, morphology, mo-
tility and viability were evaluated.
The sperm counting was performed using the hemocytometer. One
ml of sperm suspension was diluted with 9ml normal saline 3% to keep
sperms completely immobilized for counting. Then one drop of the
diluted suspension was transferred to the Neubauer slide. After 5min,
the intact sperms were counted under a light microscope according to
the World Health Organization (WHO) manual. For evaluation of
morphology, sperm suspension was smeared on a microscopic slide,
allowed to dry, then ﬁxed and stained. The slides were viewed under a
light microscope. Abnormalities in sperm morphology, including head,
tail and head-neck connection were analyzed. Sperm motility was
tested under 400× magniﬁcation. Sperms with diﬀerent motility
characteristics including motile, immobile, hyperactive, and sperms
with the progressive movement were counted in each ﬁeld. To de-
termine the percentage of viable sperm, one drop of the sperm sus-
pension was placed on a microscopic slide, then stained with Eosin B
(Sigma-Aldrich, Germany). Viable sperms had a white color while non-
viable sperms appeared as purple to red. At least 100 spermatozoa were
counted. Sperm viability was expressed as the percentage of live
sperms. The volume of sperms was calculated by cylinder and their
color was determined by ocular assessment.
2.3. Biochemical assessments
2.3.1. Lipid peroxidation (LPO) assay
Thiobarbituric acid reactive substances (TBARS) assay was used to
measure lipid peroxidation which is based on the reaction of mal-
ondialdehyde (MDA) and thiobarbituric acid (TBA) in the glacial acetic
acid medium. Samples were ﬁrst mixed with 1.5ml tri-chloro-acetic
acid (20% w/v), then centrifuged at 3000g. The taken pellets were re-
suspended with 1.5ml 2-thiobarbituric acid (0.2% w/v) and 1.5ml
H2SO4 (0.05M), following by incubation in boiling water for 45min.
Afterwards, samples were ﬁrst mixed with 2ml n-butanol, allowed to
cool, then centrifuged and their absorption was read at 532 nm. The
tetraethoxypropan standard curve was used to determine the con-
centrations [23].
2.3.2. Total antioxidant capacity (TAC) assay
Total antioxidant capacity (TAC) was measured using the ferric
reducing ability of plasma (FRAP) method which is based on the ability
of biological antioxidants in reducing Fe3+ to Fe2+ in the presence of
TPTZ (2,4,6 tripyridyl-s-triazine). This reaction results in a blue color
complex with maximum absorbance in the 593 nm [24].
2.3.3. Total thiol groups (TTG) assay
Plasma TTG was evaluated using DTNB as a reagent. Brieﬂy, 1ml of
tris buﬀer (250mM tris, 2 mM EDTA, pH=8) was mixed with 50 μL of
each sample. By adding DTNB, the reaction with thiol molecules re-
sulted in the formation of a yellow complex with a maximum optical
absorbance at 412 nm [25].
2.3.4. Total protein assay
The protein content was quantiﬁed by the Bradford method. 750 uL
diluted coomassie blue was mixed with 50 μL of samples. After 10min
incubation in room temperature, absorbance of samples was measured
in 595 nm. A standard curve was created using bovine serum albumin
ranging from 0.25mg/ml to 1mg/ml [24].
2.4. Histopathology assessments
The testis samples were ﬁxed in neutral 10% formalin for 24 h at
room temperature, then dehydrated in ethanol, cleared in xylene and
ﬁnally embedded in paraﬃn. Slices of 4–6 μm thickness were prepared
and stained with hematoxylin (5 min at room temperature) and eosin
(2min at room temperature). The sections were examined under a light
microscope.
2.5. Statistical analysis
The analysis was performed using SPSS software version 16.0 (SPSS
Inc., Chicago-USA). Results were expressed as mean ± SD. The statis-
tical mean diﬀerence between groups was evaluated using one-way test
followed by Tukey test. Diﬀerences were considered signiﬁcant if the p
value was<0.05.
3. Results
3.1. Tempol eﬀect on fasting blood sugar
FBS levels was measured in the ﬁrst day and at the end of the
treatment. At the beginning of the treatment, FBS was signiﬁcantly
higher in T2D and treated T2D groups compared to the healthy control
group (p < 0.001). However, Treatment of T2D group with Tempol
100mg/kg caused a dramatic decrease in FBS compared to diabetic
group (p < 0.001) did not reduce FBS to the normal range
(p < 0.001) (Fig. 1).
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3.2. Tempol eﬀect on body weight
Final body weight signiﬁcantly decreased in the T2D group
(p < 0.001) compared to the normal controls. Diabetic rats treated
with Tempol, however, showed signiﬁcant improvement in their body
weight (p < 0.001) (Fig. 2).
3.3. Tempol eﬀect on sperm count
The evaluation of sperm counts indicated that the number of sperms
in the T2D group was strikingly decreased compared to the control
group (p < 0.001). Treatment of diabetic rats with Tempol sig-
niﬁcantly increased the sperm count compared to the untreated T2D
group (p < 0.05), but did not restore the sperm count to the range of
the healthy group (p < 0.01) (Fig. 3).
3.4. Tempol eﬀect on sperm morphology
Morphological observation showed that spermatozoa with abnormal
morphology signiﬁcantly increased in T2D rats compared to the control
group (p < 0.001). Tempol treatment decreased the number of ab-
normal sperm in T2D (p < 0.01) and control (p < 0.001) rats com-
pared to untreated T2D rats (Fig. 4).
3.5. Tempol eﬀect on sperm motility
The results of sperm motility showed that the number of motile
(p < 0.001), forward movement (p < 0.001) and hyperactive
(p < 0.01) sperms in T2D rats signiﬁcantly decreased and the number
of immobile sperm (p < 0.001) signiﬁcantly increased compared to
the control group. Treatment of diabetic rats with Tempol increased the
motile (p < 0.01), forward movement immobile (p < 0.01), and hy-
peractive sperms immobile (p < 0.01), but reduced the number of
immobile sperm in comparison to the untreated diabetic group
(p < 0.05) (Fig. 5).
3.6. Tempol eﬀect on sperm viability
The viability test showed that the number of viable sperms in T2D
rats far lower compared to the control group immobile (p < 0.001).
Treating with Tempol increased viable sperm compared to the
Fig. 1. Tempol eﬀect on FBS. The data are presented as mean ± SD. C: control
group, D: type 2 diabetic group, T: Tempol 100mg/kg, FBS: fasting blood sugar.
†Signiﬁcantly diﬀerent compared to untreated control group (†††p < 0.001).
⁎Signiﬁcantly diﬀerent compared to untreated diabetic group (***p < 0.001).
Fig. 2. Tempol eﬀect on body weight. The data are presented as mean ± SD. C:
control group, D: type 2 diabetic group, T: Tempol 100mg/kg. †Signiﬁcantly
diﬀerent compared to untreated control group (††p < 0.01, ††† p < 0.001). ⁎
Signiﬁcantly diﬀerent compared to untreated diabetic group (***p < 0.001).
Fig. 3. Tempol eﬀect on sperm count. The data are presented as mean ± SD. C:
control group, D: type 2 diabetic group, T: Tempol 100mg/kg. † Signiﬁcantly
diﬀerent compared to untreated control group (††† p < 0.001). ⁎ Signiﬁcantly
diﬀerent compared to untreated diabetic group (*p < 0.05, ** p < 0.01).
Fig. 4. Tempol eﬀect on sperm morphology. The data are presented as
mean ± SD. C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg.
† Signiﬁcantly diﬀerent compared to untreated control group (†††p < 0.001).
* Signiﬁcantly diﬀerent compared to untreated diabetic group (**p < 0.01,
*** p < 0.001).
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untreated diabetic group (p < 0.01) (Fig. 6).
3.7. Tempol eﬀect on lipid peroxidation (LPO)
The levels of malondialdehyde (MDA), as an LPO index, rose in the
T2D group compared to the control group (p < 0.001). Treatment of
diabetic rats with Tempol reduced MDA levels compared to the un-
treated diabetic group (p < 0.01) (Fig. 7).
3.8. Tempol eﬀect on total antioxidant capacity (TAC)
Total antioxidant capacity (TAC) in the diabetic group was sig-
niﬁcantly reduced compared to the control group (p < 0.001).
However, in the diabetic group receiving Tempol, the TAC restored
signiﬁcantly in comparison to the diabetic group (p < 0.01) (Fig. 8).
3.9. Tempol eﬀect on total thiol groups (TTG)
The results of this study showed that the levels of TTG in the studied
groups were not statistically signiﬁcant (p > 0.05) (Fig. 9).
3.10. Histopathological ﬁndings
Histopathological evaluation of right testis is presented in Table 1.
T2D mellitus caused a dramatic decrease in the count of spermatogonia
(p < 0.001), primary spermatocytes (p < 0.001), late spermatids
(p= 0.01) and leydig cells (p < 0.001) compared to normal controls.
Treatment of T2D rats with Tempol did not improve these parameters
(p > 0.05).
The number of early spermatid in T2D group showed reduction in
comparison with the normal group, but this diﬀerence was not sig-
niﬁcant (p > 0.05). The number of sertoli cells was not signiﬁcantly
diﬀerent between groups (p > 0.05).In the microscopic evaluation of
tissue sections from control group no abnormal structure was observed;
arrangement of cells inside the seminiferous tubules, their number, and
the thickness of membrane and tubules were normal.
Histopathological studies in the diabetic group indicated that
seminiferous tubules altered. Thickening of the basal membrane, dis-
rupting in a cellular arrangement on the base membrane, decreasing all
Fig. 5. Tempol eﬀect on sperm motility. The data are presented as Mean ± SD.
C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg. † Signiﬁcantly
diﬀerent compared to untreated control group (†††p < 0.001, ††p < 0.01). *
Signiﬁcantly diﬀerent compared to untreated diabetic group (*p < 0.05, **
p < 0.01, *** p < 0.001).
Fig. 6. Tempol eﬀect on sperm viability. The data are presented as mean ± SD.
C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg. † Signiﬁcantly
diﬀerent compared to untreated control group (†††p < 0.001). * Signiﬁcantly
diﬀerent compared to untreated diabetic group (**p < 0.01, ***p < 0.001).
Fig. 7. Tempol eﬀect on MDA levels of testis tissue. The data are presented as
mean ± SD. C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg,
MDA: malondialdehyde. † Signiﬁcantly diﬀerent compared to untreated control
group (†††p < 0.001). * Signiﬁcantly diﬀerent compared to untreated diabetic
group (** p < 0.01, *** p < 0.001).
Fig. 8. Tempol eﬀect on TAC levels in testis tissue. The data are presented as
mean ± SD. C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg,
TAC: total antioxidant capacity. † Signiﬁcantly diﬀerent compared to untreated
control group (†††P < 0.001). * Signiﬁcantly diﬀerent compared to untreated
diabetic group (**p < 0.01, *** P < 0.001).
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cell types, increasing vacancy and the presence of giant cells in some of
the seminiferous tubules were observed in these examinations. The
severity of the lesions in the diabetic group treated with Tempol re-
duced.
4. Discussion
T2D is one of the most common type of metabolic disorder that
aﬀects male fertility capability [25]. The present study revealed that
Tempol as a synthetic antioxidant modulates FBS, increases antioxidant
capacity in testis tissue and also improves fertility related parameters in
T2D model.
The destructive eﬀect of T2D on male fertility have been indicated
by previous studies [26]. Indeed, T2D caused disruption of seminiferous
tubular morphology and thereby decreased the serum levels of gona-
dotropins and testosterone, number of leydig and sertoli cells and sperm
production that ﬁnally aﬀect the fertility capacity [27].
Chronic hyperglycemia is one of the key factors that link DM to the
infertility. It has been shown that hyperglycemia and insulin resistance
induce the free radicals formation and reactive oxygen species [28].
Our results revealed that T2D decreased the levels of some sperm
parameters such as; sperm count, motility and viability and also in-
creased the count of sperm with abnormal morphology. Consistent with
our results, defective eﬀects of DM on the sperm parameters have been
documented by previous studies [29,30].
The research ﬁndings indicated that the DM can lead to alter in
histopathology of testis [31]. Furthermore, scientiﬁc evidences show in
diabetes, in addition to degeneration and vacuolization of spermato-
gonia, spermatocytes and spermatids, the size of the seminiferous tu-
bules is also decreased [32,33]. The ﬁndings of the present study were
consistent with these studies, emphasizing damaging eﬀects of DM on
testis.
Destructive eﬀects of hyperglycemia on male reproductive system
are interpreted by various mechanisms. It has been established that
hyperglycemia induces generation of ROS and reactive nitrogen species
(RNS) [34]. Oxidative stress induced by diabetes is correlated with the
vascular disorders, endothelial dysfunction and neuropathy in erectile
tissue [35]. Furthermore, oxidative stress has several harmful eﬀects
such as testicular atrophy, decrease in body weight and sexual organs
and also reduction in sperm count [29].
The membrane of sperm cells is enriched with poly unsaturated
fatty acids (PUFA), this makes them very vulnerable to T2D-oxidative
damage [10]. The reaction of free radicals membrane fatty acids can
then lead to decrease in sperm motility, inactivation of glycolytic, DNA
oxidation and ultimately sperm failure in oocyte fertilization [36].
Therefore, it can be concluded that antioxidant supplementing might be
one of the eﬀective therapeutic strategies to counteract eﬀects of T2D
on fertility [29]. There is evidences that the administration of anti-
oxidants can protect the sperm cell DNA against ROS-induced damage,
thereby improve sperm quality [37,38]. Tempol provides anti-oxidant
eﬀects by mimicking the activity of SOD enzyme, it might therefore
have protective eﬀects against associated complication of oxidative
stress [18]. Murawski et al. revealed a positive correlation between
SOD activity in seminal plasma and semen quality parameters [39]. In
another study, Negri et al. evaluated the eﬀectiveness of SOD-based
antioxidant supplementation in the reducing of sperm DNA fragmen-
tation. Their results showed that this supplementation has a beneﬁcial
eﬀects on integrity of sperm DNA [40].
The present study showed that the Tempol has a modulated eﬀect
on the FBS. In line with our results, Jabbarpour et al. showed that
Tempol reduced FBS in diabetic rats [41]. The proposed mechanism for
this issue is that Tempol improved pancreas function by induction of
insulin production [42].
The current study showed that STZ caused a signiﬁcant decrease in
body weight but treatment with Tempol modulated it. Insulin promotes
glycogen and lipid synthesis in muscle cells, therefore, insulin deﬁ-
ciency under diabetes condition decreases the uptake of glucose by
muscles, increases lipolysis and gluconeogenesis and subsequently lead
to muscle atrophy and weight loss [43]. In agreement with our ﬁndings,
previous studies have shown that Tempol is able to recover weight and
improves glucose and insulin levels in diabetic rats [44].
On the other hand, our results showed that the TAC and MDA levels
signiﬁcantly decreased and increased, respectively, in T2D rats com-
pared to the control which is consistent with previous studies [16,45].
It has been established that excessive generation of ROS under hy-
perglycemia condition induces damage to macromolecules which is
associated with the development and progression of T2DM [36].
In the present study, Tempol modulates the eﬀects of T2D-induced
oxidative stress through the mimicking the activity of SOD.
Furthermore, our recent study on diabetic nephropathy also showed
that Tempol administration might increase the glutathione peroxidase
activity [46].
Overall, Tempol seems to play an important role in protecting the
sperm membrane against ROS-induced lipid peroxidation, thereby im-
provement the quality of sperm parameters.
Fig. 9. Tempol eﬀect on TTG levels in testis tissue. The data are presented as
mean ± SD. C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg,
TTG: total thiol groups.
Table 1
Count of typical germ cells right testis of studied groups.
Group Spermatogonia Primary spermatocytes Early spermatids Late spermatids Sertoli cells Leydig cells
C 30.35 ± 1.74 40.10 ± 1.98 56.60 ± 3.02 19.25 ± 0.82 6.95 ± 0.27 15.55 ± 0.59
D 21.50 ± 1.22⁎ 24.30 ± 1.18⁎ 42.70 ± 3.16 12.05 ± 2.94⁎ 5.65 ± 0.29 10.25 ± 0.39⁎
C+T 30.90 ± 1.67 41.95 ± 1.87 59.20 ± 2.76 20.75 ± 0.90 6.80 ± 0.27 12.20 ± 0.40
D+T 22.10 ± 1.07 27.20 ± 0.94 47.85 ± 3.58 14.40 ± 0.82 6.05 ± 0.30 12.55 ± 0.45
The data are presented as mean ± SD. C: control group, D: type 2 diabetic group, T: Tempol 100mg/kg.
⁎ Signiﬁcantly diﬀerent compared to control group (p < 0.05).
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5. Conclusion
Therefore, it can be concluded that Tempol may be a candidate
antioxidant to counteract the harmful eﬀects of T2D on fertility cap-
ability. Finally, this study has few limitations including: evaluation of
sperm DNA fragmentation, expression of GLUT genes, increasing the
duration of study and evaluation of sperm fertilizing capacity under in
vitro condition.
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